Filamentous Hemagglutinin Protein (FHA)
FHA
Origin: Human
Host: Bordetella pertussis
Native
> 95 % pure
ELISA
-
- Target
- Filamentous Hemagglutinin (FHA)
- Protein Type
- Native
- Origin
- Human
-
Source
- Bordetella pertussis
- Application
- ELISA
- Characteristics
-
Filamentous Hemagglutinin purified from Bordetella Pertussis
Protein Source: Bordetella Pertussis - Purity
- > 95 % pure
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Comment
-
Custom sizes are available on request to antibodies@fitzgerald-fii.com
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.87 mg/mL
- Buffer
- Frozen liquid.
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -80 °C
- Storage Comment
- Store at -70 °C.
-
- Target
- Filamentous Hemagglutinin (FHA)
- Alternative Name
- Filamentous Hemagglutinin
- Target Type
- Viral Protein
- Background
-
Filamentous haemagglutinin adhesin (FHA) is an important virulence factor from Bordetella pertussis related to the adhesion and spread of the bacteria through the respiratory tract. Filamentous hemagglutinin is a 220 kDa protein associated with the bacterial surface, but also secreted in substantial amounts. Studies using FHA-deficient B. pertussis strains implicate this protein in tracheal colonization, cell adherence, and invasion of macrophages and epithelial cells by B. pertussis. FHA is a useful tool in immunoassays and whooping cough vaccination studies.
Description: Bordetella Pertussis.
Alternative Names: FHA, Bordetella Pertussis, Purified FHA - Molecular Weight
- 220 kDa
-
You are here:
